Anthera Pharmaceuticals Slides on Missed Late Stage Results
Shares of Anthera Pharmaceuticals lost roughly one-third of their value on Thursday after the company gave an update on its late-stage Lupus clinical trial.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 187
Short Interest Bets Increase on Major Pharma
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
Short Sellers Grow More Selective on Major Biotechs
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for just now…
Mylan Rises on Mixed Earnings
Mylan N.V. (NASDAQ: MYL) released third-quarter earnings after markets closed on Wednesday. The company posted $1.38 in earnings per share (EPS) and $3.23 billion in revenue. The consensus estimates from Thomson Reuters are calling…
Novavax Announces Restructuring Along With Mixed Q3 Earnings
Novavax, Inc. (NASDAQ: NVAX) reported third-quarter financial results after markets closed on Wednesday. The company said that it had a net loss of $0.24 per share and $3.2 million in revenue, versus consensus estimates…
5 Hospitals Slaughtered on the Clinton Loss (or Trump Win)
If there was one group of companies which actually got off close to Scott-free during the Obamacare experiment, it was the for-profit hospitals. They were in many cases immune from having to be so…
Sucampo Pharmaceuticals Rises on Solid Earnings Beat and Guidance
Sucampo Pharmaceuticals reported better-than-expected third-quarter financial results before the markets opened on Wednesday.
What to Expect From Mylan Earnings
EpiPen maker Mylan is scheduled to report its third-quarter financial results after the markets close on Wednesday.
Ionis Pharmaceuticals Rises Despite Missing Earnings
Ionis Pharmaceuticals reported disappointing third-quarter financial results before the markets opened on Wednesday.
Why Arrowhead Pharmaceuticals Shares Are Sliding
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
BioScrip Falls on Weak Earnings and Guidance
BioScrip, Inc. (NASDAQ: BIOS) reported third-quarter financial results before the markets opened on Tuesday. The company said that it had a net loss of $0.09 per share and $224.5 million in revenues. There were…
What to Look for in Novavax Earnings
Novavax is scheduled to report its third-quarter financial results before the markets open on Wednesday.
Acadia Pharmaceuticals Jumps on Incredible Earnings
After Acadia Pharmaceuticals released its third-quarter earnings report after the markets closed on Monday, shares rose sharply Tuesday morning.
Depomed Tumbles on Missed Earnings
After Depomed reported disappointing third-quarter financial results after the markets closed on Monday, shares tumbled early Tuesday.
Analyst Has 4 Biotech Stocks to Buy Now as Risk Has Dropped Dramatically
RBC thinks investors can buy these biotech stocks now, because the timing in their view is irrelevant, and they see the stocks de-risked and having mergers and acquisitions potential.